OLD Category: signatures

The GARDpotency Assay for Potency-Associated Subclassification of Chemical Skin Sensitizers—Rationale, Method Development, and Ring Trial Results of Predictive Performance and Reproducibility

• Gradin R, Johansson A, Forreryd A, Aaltonen E, Jerre A, Larne O, Mattson U, Johansson H

Upregulation of follistatin and low apoptotic activity in intraductal oncocytic papillary neoplasm of the pancreatobiliary system

• Nakahodo J, Fukumura Y, Saito T, Hirabayashi K, Doi R, Hayashi T, Yao T

Proteomic Tissue-Based Classifier for Early Prediction of Prostate Cancer Progression

• Gao Y, Wang YT, Chen Y, Wang H, Young D, Shi T, Song Y, Schepmoes AA, Kuo C, Fillmore TL, Qian WJ, Smith RD, Srivastava S, Kagan J, Dobi A, Sesterhenn IA, Rosner IL, Petrovics G, Rodland KD, Srivastava S, Cullen J, Liu T.

Zinc Gluconate Induces Potentially Cancer Chemopreventive Activity in Barrett’s Esophagus: A Phase 1 Pilot Study

• Valenzano M, Rybakovsky E, Chen V...Kossenkov A, Fong L, Mullin J

CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage

• Eckstein M, Epple E, Jung R...Wullich B, Taubert H, Wach S

Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials

• Dienstmann R, Garralda E, Aguilar S...Rodon J, Nuciforo P, Vivancos A

Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures

• Vander Velde R, Yoon N, Marusyk V, Durmaz A, Dhawan A, Miroshnychenko D, Lozano-Peral D, Desai B, Balynska O, Poleszhuk J, Kenian L, Teng M, Abazeed M, Mian O, Tan AC, Haura E, Scott J, Marusyk A.

Integrative genomics approach identifies molecular features associated with early-stage ovarian carcinoma histotypes

• Engqvist H, Parris TZ, Biermann J, Rönnerman EW, Larsson P, Sundfeldt K, Kovács A, Karlsson P, Helou K.

Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors

• Lahiguera Á, Hyroššová P, Figueras A, Pujana MÀ, Perales JC, Viñals F

GeoMx RNA Assay: High Multiplex, Digital, Spatial Analysis of RNA in FFPE Tissue

• Zollinger DR, Lingle SE, Sorg K, Beechem JM, Merritt CR

Platform independent protein-based cell-of-origin subtyping of diffuse large B-cell lymphoma in formalin-fixed paraffin-embedded tissue

• Reinders J, Altenbuchinger M, Limm K, Klapper W, Spang R, Oefner PJ

Cytoplasmic TDP43 Binds microRNAs: New Disease Targets in Amyotrophic Lateral Sclerosis

• Paez-Colasante X, Figueroa-Romero C, Rumora AE, Hur J, Mendelson FE, Hayes JM, Backus C, Taubman GF, Heinicke L, Walter NG, Barmada SJ, Sakowski SA, Feldman EL.